多发性硬化上颈髓面积年龄相关与疾病特异性效应解析
本研究为横断面多中心研究,纳入480名健康对照和1295例多发性硬化患者,采用主动表面法测量C1至C2/3水平上颈髓面积并按头围归一化。结果显示多发性硬化患者自30岁起归一化上颈髓面积Z评分低于零,尤其在第五、第六个十年,且该萎缩与残疾和结构MRI指标相关。
要点
- 多发性硬化患者上颈髓萎缩超出年龄相关效应,第五、第六个十年最明显。
- 疾病特异性萎缩与性别无关,不同起病年龄组的差异主要反映病程。
- 上颈髓萎缩与残疾和结构MRI指标相关,可作为神经退行性生物标志物。
核心结论
- 多发性硬化患者上颈髓面积减少超出年龄相关效应,尤其在第五、第六个十年,之后随年龄增长效应增加而减弱。
- 疾病特异性萎缩与性别无关,不同起病年龄组的差异主要反映病程。
- 上颈髓萎缩与残疾和结构MRI指标相关,支持其作为多发性硬化相关神经退行性生物标志物。
研究设计与样本
- 横断面、多中心研究,纳入意大利3个中心的健康对照和年龄18-70岁、无其他脊髓病变的多发性硬化患者。
- 采集3.0T脑MRI T1加权容积图像和临床数据,测量C1至C2/3水平上颈髓面积并按头围归一化。
- 健康对照n=480,中位年龄41.0岁,女性59%;多发性硬化患者n=1295,中位年龄42.0岁,女性68%。
主要发现
- 健康对照归一化上颈髓面积随年龄呈非线性关系,至30岁代末增加(p≤0.033),50岁后下降(p≤0.008)。
- 多发性硬化患者自30岁起归一化上颈髓面积Z评分低于零(p≤0.039),尤其在第五、第六个十年。
- 斜率分析显示多发性硬化患者成年早期至40岁代末明显下降,之后减弱,男女间无差异。
- 儿童起病多发性硬化Z评分低于成人起病和晚发起病(p<0.001),但病程调整后差异不显著(p=0.823);疾病驱动的年龄相关下降在各起病组间无差异(p=0.668)。
- 上颈髓萎缩程度与残疾和结构MRI指标相关(绝对ρ范围0.196-0.392,均p<0.001)。
临床怎么用
- 上颈髓面积测量可辅助识别多发性硬化中超出年龄效应的神经退行性改变。
- 解读上颈髓萎缩时应考虑年龄和病程,尤其儿童起病患者的差异多由病程较长解释。
- 上颈髓萎缩与残疾和结构MRI指标相关,可作为监测疾病进展的敏感影像标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Cervical cord atrophy is a key predictor of disability and disease progression in multiple sclerosis (MS); however, age-related vs disease-related contributions remain unclear. Here, we investigated whether MS results in a disease-specific reduction in mean upper cervical cord area (MUCCA) beyond aging, and whether this deviation is modulated by sex and age at disease onset. METHODS: In this cross-sectional, multicenter study (3 Italian sites), we analyzed volumetric T1-weighted 3.0T brain MRIs and clinical data from healthy controls (HCs) and patients with MS (ages 18-70 years) without other cord pathology. Active-surface MUCCA measurements were obtained between C1 and C2/3 and normalized for head size (nMUCCA). nMUCCA lifespan trajectories were modelled in HC using polynomial regression accounting for age, age squared, sex, scanner, and interaction terms. Such model was applied to patients with MS generating nMUCCA Z-scores, capturing disease-specific atrophy beyond aging. Effects of sex and age at onset (pediatric onset <18, adult onset 18-49, and late onset ≥50 years) were evaluated, along with associations with disability, disease duration, T2 hyperintense lesion, and normalized brain volumes. RESULTS: In HC (n = 480, median age 41.0 years, 59% female), nMUCCA showed a nonlinear age relationship, increasing until late 30s (p ≤ 0.033) and declining after age 50 years (p ≤ 0.008). Patients with MS (n = 1,295, median age 42.0 years, 68% female) showed cord Z-scores below zero from age 30 years (p ≤ 0.039), particularly in the fifth and sixth decades, indicating reductions vs HC. Slope analysis further revealed marked early-adult decline up to late 40s, with attenuation thereafter. These patterns did not differ between men and women. Pediatric-onset MS exhibited lower Z-scores (p < 0.001) vs adult-onset and late-onset patients, but differences were not significant (p = 0.823) after disease duration adjustment. Disease-driven decline with age did not differ among onset groups (p = 0.668). Greater upper cervical cord atrophy correlated with higher disability and worse structural MRI measures (absolute ρ range = 0.196-0.392, all p < 0.001). DISCUSSION: In MS, upper cord atrophy exceeds age-related effects, especially in fifth-sixth decades, and attenuates later as aging effects increase. Disease-specific atrophy is independent of sex. Differences across onset groups largely reflect disease duration. Upper cord atrophy correlates with disability, supporting its role as a sensitive MS-related neurodegeneration biomarker beyond aging.
引用
- Jain K, Storelli L, Valsasina P, et al. Disentangling Age-Related and Disease-Specific Effects on Upper Cervical Cord Area in Patients With Multiple Sclerosis. Neurology. 2026. PMID: 42814910. doi:10.1212/WNL.0000000000218517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。